Latest Insider Transactions at Mind Medicine (Mind Med) Inc. (MNMD)
This section provides a real-time view of insider transactions for Mind Medicine (Mind Med) Inc. (MNMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Mind Medicine (MindMed) Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Mind Medicine (MindMed) Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2024
|
David W Gryska |
BUY
Open market or private purchase
|
Direct |
2,500
+11.19%
|
$17,500
$7.17 P/Share
|
|
Sep 25
2024
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
19,771
-3.5%
|
$98,855
$5.98 P/Share
|
|
Sep 25
2024
|
Carrie Liao Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,352
-2.31%
|
$11,760
$5.98 P/Share
|
|
Sep 25
2024
|
Mark Sullivan Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,430
-2.43%
|
$22,150
$5.98 P/Share
|
|
Sep 25
2024
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,871
-1.95%
|
$34,355
$5.98 P/Share
|
|
Aug 23
2024
|
David W Gryska |
BUY
Open market or private purchase
|
Direct |
3,500
+16.79%
|
$17,500
$5.98 P/Share
|
|
Aug 21
2024
|
Miri Halperin Wernli Executive President |
SELL
Payment of exercise price or tax liability
|
Direct |
32,595
-13.87%
|
$195,570
$6.17 P/Share
|
|
Aug 21
2024
|
Miri Halperin Wernli Executive President |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+17.54%
|
$150,000
$3.7 P/Share
|
|
Aug 20
2024
|
Robert Barrow Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
500
+0.09%
|
$3,000
$6.12 P/Share
|
|
Aug 19
2024
|
Robert Barrow Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
500
+0.09%
|
$3,000
$6.31 P/Share
|
|
Jun 25
2024
|
Mark Sullivan Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
17,854
-8.93%
|
$124,978
$7.22 P/Share
|
|
Jun 25
2024
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,659
-2.7%
|
$109,613
$7.22 P/Share
|
|
Jun 25
2024
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,925
-1.93%
|
$48,475
$7.22 P/Share
|
|
Mar 25
2024
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,519
-2.77%
|
$148,671
$9.5 P/Share
|
|
Mar 25
2024
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,578
-1.8%
|
$59,202
$9.5 P/Share
|
|
Mar 25
2024
|
Schond L. Greenway Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,560
-2.57%
|
$50,040
$9.78 P/Share
|
|
Dec 26
2023
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,774
-1.82%
|
$20,322
$3.63 P/Share
|
|
Dec 26
2023
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,237
-2.17%
|
$39,711
$3.63 P/Share
|
|
Dec 26
2023
|
Schond L. Greenway Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,652
-2.54%
|
$16,956
$3.63 P/Share
|
|
Sep 25
2023
|
Schond L. Greenway Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,762
-1.27%
|
$17,286
$3.58 P/Share
|
|
Sep 25
2023
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,918
-0.92%
|
$20,754
$3.58 P/Share
|
|
Sep 25
2023
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,499
-1.09%
|
$40,497
$3.58 P/Share
|
|
Aug 25
2023
|
Schond L. Greenway Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-8.06%
|
$60,000
$3.8 P/Share
|
|
Jun 27
2023
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,502
-1.22%
|
$46,506
$3.2 P/Share
|
|
Jun 27
2023
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,783
-0.88%
|
$20,349
$3.2 P/Share
|
|
Jun 27
2023
|
Schond L. Greenway Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,635
-2.26%
|
$34,905
$3.2 P/Share
|
|
Jun 21
2023
|
David W Gryska |
BUY
Grant, award, or other acquisition
|
Direct |
13,851
+50.0%
|
-
|
|
Jun 21
2023
|
Andreas Krebs |
BUY
Grant, award, or other acquisition
|
Direct |
13,671
+47.51%
|
-
|
|
Jun 21
2023
|
Roger Crystal |
BUY
Grant, award, or other acquisition
|
Direct |
13,671
+41.06%
|
-
|
|
Jun 21
2023
|
Suzanne Louise Bruhn |
BUY
Grant, award, or other acquisition
|
Direct |
13,671
+41.06%
|
-
|
|
Jun 21
2023
|
Carol A Vallone |
BUY
Grant, award, or other acquisition
|
Direct |
13,671
+45.25%
|
-
|
|
Apr 13
2023
|
Mark Sullivan Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+50.0%
|
-
|
|
Mar 14
2023
|
Dan Karlin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+24.49%
|
-
|
|
Mar 14
2023
|
Carrie Liao Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+13.55%
|
-
|
|
Mar 14
2023
|
Robert Barrow Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+38.5%
|
-
|
|
Mar 14
2023
|
Schond L. Greenway Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
175,000
+10.8%
|
-
|
|
Mar 14
2023
|
Miri Halperin Wernli Executive President |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+6.78%
|
-
|
|
Mar 01
2023
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,577
-1.35%
|
$10,731
$3.51 P/Share
|
|
Mar 01
2023
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,273
-3.35%
|
$24,819
$3.51 P/Share
|
|
Dec 21
2022
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,211
-0.46%
|
$2,422
$2.69 P/Share
|
|
Dec 21
2022
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,861
-1.54%
|
$7,722
$2.69 P/Share
|
|
Oct 27
2022
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
644
-0.24%
|
$1,932
$3.0 P/Share
|
|
Oct 25
2022
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
541
-0.2%
|
$1,082
$2.81 P/Share
|
|
Oct 25
2022
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,207
-0.48%
|
$2,414
$2.81 P/Share
|
|
Oct 18
2022
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,220
-0.48%
|
$3,660
$3.11 P/Share
|
|
Sep 27
2022
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
640
-0.24%
|
$3,200
$5.87 P/Share
|
|
Sep 26
2022
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
565
-0.21%
|
$2,825
$5.51 P/Share
|
|
Sep 26
2022
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,264
-0.5%
|
$6,320
$5.51 P/Share
|
|
Sep 16
2022
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,350
-0.53%
|
$9,450
$7.26 P/Share
|
|
Aug 31
2022
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,204
-0.45%
|
$13,244
$11.67 P/Share
|